{"title":"Microsponge as Novel Drug Delivery System: A Review","authors":"Pratima Jayasawal, N. G. R. Rao, V. Jakhmola","doi":"10.35652/igjps.2022.12002","DOIUrl":null,"url":null,"abstract":"During the last few decades, pharmaceutical industry gave more importance to the controlled release of dosage forms like solid formulation, semi solid formulation, and topicalpreparation dueto efficacy and patient compliance. Normal topical preparations have some disadvantages like unpleasant odour, greasiness, and skin irritation reported in study cases. Also many topicalpreparations fail to reach the systemic circulation in sufficient amounts in few cases. This problem is achieved by the present formulation as microsponge in the areas of research. MDS is amicroscopic sphere capable of absorbing skin secretions, therefore reducing the oiliness of the skin. Microspongehaving particle size of 10-25 microns in diameter, have wide range of entrapmentof various ingredients in a single microsponges system and release them at desired rates.Microsponge is recent novel technique for control release and targetspecific drug delivery system. Microsponges are polymeric delivery system composed of porous microspheres. They are tiny sponge-like sphericalparticle with a large porous surface.Drug release in microsponge is done by the external stimuli like (pH, temperature, rubbing). It hasseveral advantageous over the other topical preparations are non allergenic, non toxic, non irritant, non mutagenic. Microsponges are designed to deliver apharmaceutical active ingredient efficiently at the minimum dose and alsoto enhance stability, reduce side effects and modify drug release.©2022iGlobal Research and PublishingFoundation. All rights reserved.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indo Global Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35652/igjps.2022.12002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
微海绵作为新型给药系统的研究进展
在过去的几十年里,由于疗效和患者依从性,制药工业更加重视固体制剂、半固体制剂和局部制剂等剂型的控释。正常的局部制剂有一些缺点,如难闻的气味,油腻,和皮肤刺激报道的研究案例。此外,在少数情况下,许多局部制剂不能以足够的量到达体循环。这一问题目前是通过微海绵的配方来实现的。MDS是一种能够吸收皮肤分泌物的微观球体,因此可以减少皮肤的油性。微海绵的粒径为10-25微米,在单个微海绵系统中可以广泛地捕获各种成分,并以所需的速率释放它们。微海绵是近年来发展起来的一种新型药物控释和靶向给药系统。微海绵是由多孔微球组成的高分子输送系统。它们是微小的海绵状球形颗粒,表面有很大的多孔性。微海绵中的药物释放是通过外部刺激(pH值、温度、摩擦)来完成的。与其他外用制剂相比,它具有非过敏性、无毒、无刺激性、非致突变性等优点。微海绵旨在以最小剂量有效地递送药物活性成分,并提高稳定性,减少副作用和改变药物释放。©2022全球研究与出版基金会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。